IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,297,507 | +44.0% | 7,977,474 | +122.8% | 0.02% | +50.0% |
| Q2 2023 | $25,207,903 | +120795.4% | 3,580,668 | +4.9% | 0.01% | 0.0% |
| Q1 2023 | $20,851 | +175.7% | 3,412,599 | +188.3% | 0.01% | +200.0% |
| Q4 2022 | $7,563 | -99.9% | 1,183,539 | -3.1% | 0.00% | -42.9% |
| Q3 2022 | $11,697,000 | -48.0% | 1,220,965 | -40.0% | 0.01% | -50.0% |
| Q2 2022 | $22,479,000 | -45.6% | 2,036,087 | -17.9% | 0.01% | -36.4% |
| Q1 2022 | $41,301,000 | +555.1% | 2,480,507 | +651.0% | 0.02% | +633.3% |
| Q4 2021 | $6,305,000 | +1112.5% | 330,291 | +1551.5% | 0.00% | – |
| Q2 2021 | $520,000 | -97.8% | 20,000 | -97.3% | 0.00% | -100.0% |
| Q1 2021 | $23,143,000 | +86.5% | 730,977 | +173.3% | 0.02% | +77.8% |
| Q4 2020 | $12,409,000 | -59.1% | 267,428 | -71.0% | 0.01% | -75.7% |
| Q3 2020 | $30,340,000 | +88.1% | 921,645 | +56.9% | 0.04% | +68.2% |
| Q2 2020 | $16,127,000 | +220.8% | 587,509 | +249.9% | 0.02% | +83.3% |
| Q1 2020 | $5,027,000 | -1.5% | 167,930 | -8.9% | 0.01% | +100.0% |
| Q4 2019 | $5,104,000 | -31.0% | 184,400 | -54.6% | 0.01% | -50.0% |
| Q3 2019 | $7,398,000 | +116.3% | 406,526 | +191.4% | 0.01% | +140.0% |
| Q2 2019 | $3,421,000 | +1854.9% | 139,500 | +657.9% | 0.01% | – |
| Q1 2019 | $175,000 | -74.2% | 18,407 | -69.5% | 0.00% | -100.0% |
| Q3 2018 | $679,000 | -92.6% | 60,387 | -91.5% | 0.00% | -91.7% |
| Q2 2018 | $9,125,000 | +5.8% | 712,922 | +39.7% | 0.01% | 0.0% |
| Q1 2018 | $8,625,000 | +66.0% | 510,364 | -21.4% | 0.01% | +71.4% |
| Q4 2017 | $5,197,000 | -67.8% | 649,651 | -68.8% | 0.01% | -72.0% |
| Q3 2017 | $16,131,000 | +411.1% | 2,081,480 | +384.7% | 0.02% | +316.7% |
| Q2 2017 | $3,156,000 | – | 429,435 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |